Warning: The NCBI web site requires JavaScript to function. more...
Multiple primary tumours: incidence estimation in the presence of competing risks.
Rosso S, Terracini L, Ricceri F, Zanetti R.
Popul Health Metr. 2009 Apr 1;7:5.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Methodological issues in estimating survival in patients with multiple primary cancers: an application to women with breast cancer as a first tumour.
Rosso S, Ricceri F, Terracini L, Zanetti R.
Emerg Themes Epidemiol. 2009 Feb 27;6:2.
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS.
Oncologist. 1996;1(5):326-330.
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F, Camerin E, Feriani M, Nordio M, Piccoli A, Rossi B, Tessitore N.
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56. Italian.
Incidence of second primary cancers in three Italian population-based cancer registries.
Buiatti E, Crocetti E, Acciai S, Gafà L, Falcini F, Milandri C, La Rosa M.
Eur J Cancer. 1997 Oct;33(11):1829-34.
Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparén P, Tryggvadottir L, Weiderpass E, Kjaerheim K.
Acta Oncol. 2009;48(5):646-790.
Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.
Adv Exp Med Biol. 2007;608:1-22. Review.
Long-term impact of reproductive factors on cancer risk.
La Vecchia C, Negri E, Franceschi S, Parazzini F.
Int J Cancer. 1993 Jan 21;53(2):215-9.
Risk of breast cancer in relation to reproductive factors in Denmark.
Ewertz M, Duffy SW.
Br J Cancer. 1988 Jul;58(1):99-104.
Epidemiology of breast cancer.
Marchant DJ.
Clin Obstet Gynecol. 1982 Jun;25(2):387-92.
Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE.
J Natl Cancer Inst. 2008 Dec 17;100(24):1771-9. Epub 2008 Dec 9.
Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study.
Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA; UK Clinical Cytogenetics Group.
Lancet Oncol. 2008 Mar;9(3):239-46. Epub 2008 Feb 20.
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
[No authors listed]
Lancet. 1998 May 16;351(9114):1451-67.
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fosså SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB.
J Natl Cancer Inst. 2007 Nov 7;99(21):1634-43. Epub 2007 Oct 30.
Summary: multiple primary cancers in Connecticut, 1935-82.
Curtis RE, Boice JD Jr, Kleinerman RA, Flannery JT, Fraumeni JF Jr.
Natl Cancer Inst Monogr. 1985 Dec;68:219-42.
Estimation of individualized probabilities of developing breast cancer for Japanese women.
Ueda K, Tsukuma H, Tanaka H, Ajiki W, Oshima A.
Breast Cancer. 2003;10(1):54-62.
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer.
Lancet. 1996 Jun 22;347(9017):1713-27.
The lifetime risk of developing breast cancer.
Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T.
J Natl Cancer Inst. 1993 Jun 2;85(11):892-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on